reference/20378062

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20378062

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2045-2322
issueIdentifier	1
pageRange	1299-
publicationName	Scientific Reports
startingPage	1299
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_406638a2bd2eadeb47acf8d22cfaa70f
bibliographicCitation	Abe K, Kabe Y, Uchiyama S, Iwasaki YW, Ishizu H, Uwamino Y, Takenouchi T, Uno S, Ishii M, Maruno T, Noda M, Murata M, Hasegawa N, Saya H, Kitagawa Y, Fukunaga K, Amagai M, Siomi H, Suematsu M, Kosaki K; Keio Donner Project. Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19. Sci Rep. 2022 Jan 25;12(1):1299. PMID: 35079088; PMCID: PMC8789791.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_623c604caec49ad08ea7e57ba9f82f5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0966573197522c765427270cc62ebd89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2182-2076 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94b076890f31d2e74dc708e80ccf1553 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efd71cd9e7dfc40b42cfab0490333022 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30732a0f59232d031f8fa6ff7a201702 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7165-6336 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2dba0affac669b2cb58c73d516e379cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5551ebc40ca3ceb46ddfd9c8c5480c5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1138-7437 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6610-1902 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a53521d4b72ebb7c0853390bb99c9186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_669465a90b94ae9056a59d39124ed55f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63c8eaf77fecd9bf7d0a6ff56be07ed9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15fbc64c42a00ed40fc030b06c247a32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5181-179X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c395d139a7c6c307c2bec21f4616297 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4396-1664 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac8a6eefc75344d04f42c4dc5aa071be http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7311-4135 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0952-011X
date	2022-01-25^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8789791 https://pubmed.ncbi.nlm.nih.gov/35079088 https://doi.org/10.1038/s41598-022-05424-3
isPartOf	https://portal.issn.org/resource/ISSN/2045-2322 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39356
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19
discusses	http://id.nlm.nih.gov/mesh/M000733006 http://id.nlm.nih.gov/mesh/M000732393
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000086382Q000235 http://id.nlm.nih.gov/mesh/D000086782Q000235 http://id.nlm.nih.gov/mesh/D000086382Q000201 http://id.nlm.nih.gov/mesh/D062072 http://id.nlm.nih.gov/mesh/D020125 http://id.nlm.nih.gov/mesh/D000086782Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019943 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903259 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24523 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43740578

Showing number of triples: 1 to 62 of 62.